Sheila Matthews

And there's a flaw in this bill.

And what the flaw is, is it does not collect the data associated with the violence that the psychiatric drugs have.

So what we're excited about is that he is the co-sponsor of this bill.

So maybe he missed it.

Maybe he missed that loophole.

So we need to put a patch on it.

So we need to open that system up.

And he's the guy to do it now that he's got this big job and he doesn't need a bill to push through.

He can look at this flaw and say, you know what, we need to collect the data from the psychiatrists that are associated with these mass shooters.

So it protects the consumer.

There's a consumer loophole here.

This bill that he co-sponsored is more protective of the behavioral health in the drug companies.

Well, these bills are crafted by the behavioral health industry, and they're pushed onto senators and congressmen, and the voice of the consumer is often lost in there.

They go to the senators, we have a great idea, we're going to do this whole new database.

And it was bipartisan, so we're often always cautious of that because

We have to make sure that the consumer is protected.

It took us two years to get the Tennessee bill passed to test for the therapeutic levels for psychiatric drugs in mass shooters.

This bill that he sponsored has a loophole situation.

So Able Child's been chasing this data.

So you're absolutely right.